← European Medicine Shortage Tracker · all medicines

Enalapril hidroclorotiazida shortage — availability across Europe

Enalapril hidroclorotiazida currently has availability issues reported in 3 European registers: Austria, Spain, Italy.

MEDICALLY REVIEWED

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: ENALAPRIL MALEAT; HYDROCHLOROTHIAZID · ENALAPRIL HIDROCLOROTIAZIDA · ENALAPRIL + IDROCLOROTIAZIDE · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Enalapril hidroclorotiazida has active availability issues in 3 of 10 tracked European registers.
Registers reporting issues: Austria, Spain, Italy.
Latest expected-resolution date on file: 2026-09-14.
Longest-running open report: since 2026-03-18 (5 months, Spain).
Data source: 3 official medicines-agency registers, refreshed daily.

As of 7 August 2026, 3 of the 10 tracked registers list current availability issues for Enalapril hidroclorotiazida, covering 6 affected product presentations. The longest-running open report was filed in Spain on 2026-03-18 and has now been open for about 5 months. Where agencies state a cause, manufacturing problems lead with 2 of the 3 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2026-09-14; the earliest is 2026-09-14. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Spain reported first (2026-03-18), with Italy following roughly 5 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇦🇹 Austria	Shortage Co - Renitec 20 mg/12,5 mg Tabletten	2026-07-17	—	—	register ↗
🇪🇸 Spain	Shortage ENALAPRIL/HIDROCLOROTIAZIDA NORMON 20 mg/12,5 mg COMPRIMIDOS EFG, 28 comprimidos + 1 more products ENALAPRIL/HIDROCLOROTIAZIDA NORMON 20 mg/12,5 mg COMPRIMIDOS EFG, 30 comprimidos	2026-03-18	2026-09-14	Existen otros medicamentos con los mismos principios activos y misma vía. Alternatives: Existe/n otro/s medicamento/s con los mismos principios activos y para la misma vía de administración.	register ↗
🇮🇹 Italy	Shortage ENALAPRIL E IDROCLOROTIAZIDE MYLAN + 2 more products ENALAPRIL E IDROCLOROTIAZIDE MYLAN ENALAPRIL E IDROCLOROTIAZIDE PENSA	2026-08-01	—	Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available.	register ↗

New register reports per month

Full report history (6 register entries)

Every individual register entry for Enalapril hidroclorotiazida in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	ENALAPRIL E IDROCLOROTIAZIDE MYLAN	Shortage	2026-09-02	—	Problemi produttivi
🇮🇹 IT	ENALAPRIL E IDROCLOROTIAZIDE MYLAN	Shortage	2026-08-15	—	Problemi produttivi
🇮🇹 IT	ENALAPRIL E IDROCLOROTIAZIDE PENSA	Shortage	2026-08-01	—	Cessata commercializzazione definitiva
🇦🇹 AT	Co - Renitec 20 mg/12,5 mg Tabletten	Shortage	2026-07-17	—
🇪🇸 ES	ENALAPRIL/HIDROCLOROTIAZIDA NORMON 20 mg/12,5 mg COMPRIMIDOS EFG, 28 c	Shortage	2026-04-12	2026-09-14	Existen otros medicamentos con los mismos principios activos
🇪🇸 ES	ENALAPRIL/HIDROCLOROTIAZIDA NORMON 20 mg/12,5 mg COMPRIMIDOS EFG, 30 c	Shortage	2026-03-18	—	Existen otros medicamentos con los mismos principios activos

Frequently asked

Is Enalapril hidroclorotiazida currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Austria, Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Enalapril hidroclorotiazida shortage expected to end?

Agency prognoses on file range from 2026-09-14 to 2026-09-14. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Enalapril hidroclorotiazida?

5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Enalapril hidroclorotiazida availability data come from?

Directly from the official medicines-agency registers that list Enalapril hidroclorotiazida: BASG (Austria), AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Enalapril hidroclorotiazida — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/enalapril-hidroclorotiazida/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Enalapril hidroclorotiazida availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/enalapril-hidroclorotiazida/">Enalapril hidroclorotiazida shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Enalapril hidroclorotiazida: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.